NextGen Healthcare Partners with Humana to Accelerate Adoption and Exchange of Electronic Health Records

Agreement to subsidize EHRs for selected health care providers within Humana’s Medicare Advantage program; Rewards for improved clinical performance and outcomes

HORSHAM, Pa. (February 15, 2012) – NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc. (NASDAQ: QSII), and leading provider of healthcare information systems and connectivity solutions, announced today it has entered into an agreement with Humana Inc. (NYSE: HUM) to accelerate the adoption of electronic health records (EHRs) and the exchange of critical health and billing information among health care providers.

The agreement falls under Humana’s Medical Home EHR Rewards Program, whereby Humana will provide financial assistance to selected physicians for the purchase of NextGen® Ambulatory EHR and reward them for improved clinical performance.

Under this agreement, the two companies are working together to allow providers using the NextGen Ambulatory EHR to exchange patient health information with and receive payer transaction information from Humana, and then populate this critical data in the patient’s record. This collaboration enables providers to know virtually every test and procedure done for a patient across his or her entire care community. It is one of the first steps toward eliminating duplicate and unnecessary tests, as well as achieving the goals of a medical home.

Humana will subsidize NextGen Ambulatory EHR licenses for qualifying providers affording them access to patient-specific, clinical quality information; advanced clinical decision support at the point of care; and opportunities for improved care coordination.

“Humana has been impressed with the comprehensive EHR and practice management system offered by NextGen Healthcare, and we are confident that it can play an important role in transforming the quality of the patient care delivered to our members,” said Renee Buckingham, Vice President of Provider Engagement at Humana.

Scott Decker, President of NextGen Healthcare, added: “This is a great opportunity for Humana’s participating providers to gain access to EHR and practice management solutions that can enhance their practices. In addition, we intend to further collaborate on connectivity solutions, as the market transitions to a totally integrated model that will drive better quality of life for patients, improved outcomes and lower healthcare costs.”

About NextGen Healthcare

NextGen Healthcare Information Systems, Inc., a wholly owned subsidiary of Quality Systems, Inc., provides integrated clinical, financial and connectivity solutions for ambulatory, inpatient and dental provider organizations. For more information, please visit www.nextgen.com and www.qsii.com. Follow NextGen Healthcare on Twitter at www.twitter.com/nextgen or Facebook at http://www.facebook.com/NextGenHealthcare.

This news release may contain forward-looking statements within the meaning of the federal securities laws. Statements regarding future events, developments, the Company’s future performance, as well as management’s expectations, beliefs, intentions, plans, estimates or projections relating to the future (including, without limitation, statements concerning revenue and net income), are forward-looking statements within the meaning of these laws and involve a number of risks and uncertainties. Management believes that these forward-looking statements are reasonable and are based on reasonable assumptions and forecasts, however, undue reliance should not be placed on such statements that speak only as of the date hereof. Moreover, these forward-looking statements are subject to a number of risks and uncertainties, some of which are outlined below. As a result, actual results may vary materially from those anticipated by the forward-looking statements. Among the important factors that could cause actual results to differ materially from those indicated by such forward-looking statements are: volume and timing of systems sales and installations; length of sales cycles and installation process; the possibility that the products will not achieve market acceptance; seasonal patterns of sales and customer buying behavior; the development by competitors of new or superior technologies; the timing, cost and success or failure of new product and service introductions, development and product upgrade releases; undetected errors or bugs in software; product liability; changing economic, political or regulatory influences in the health-care industry; changes in product-pricing policies; availability of third-party products and components; competitive pressures including product offerings, pricing and promotional activities; the Company’s ability or inability to attract and retain qualified personnel; possible regulation of the Company’s software by the U.S. Food and Drug Administration; uncertainties concerning threatened, pending and new litigation against the Company including related professional services fees; uncertainties concerning the amount and timing of professional fees incurred by the Company generally; changes of accounting estimates and assumptions used to prepare the prior periods’ financial statements; general economic conditions; and the risk factors detailed from time to time in Quality Systems’ periodic reports and registration statements filed with the Securities and Exchange Commission. A significant portion of the Company’s quarterly sales of software product licenses and computer hardware is concluded in the last month of the fiscal quarter, generally with a concentration of such revenues earned in the final ten business days of that month. Due to these and other factors, the Company’s revenues and operating results are very difficult to forecast. A major portion of the Company’s costs and expenses, such as personnel and facilities, are of a fixed nature and, accordingly, a shortfall or decline in quarterly and/or annual revenues typically results in lower profitability or losses. As a result, comparison of the Company’s period-to-period financial performance is not necessarily meaningful and should not be relied upon as an indicator of future performance. The Company undertakes no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.

Copyright

Source: NextGen Healthcare